Investors House reported Q1 revenues of EUR 2.7m, 4% below our estimate.
Back to wallpaper growth in Q1 We lower '25e-'26e EBITA by 2-3% on Artscape-driven Q1 miss We reiter...
Nanexa continues to strengthen the foundation for the upcoming Phase Ib/II study in the NEX-22 proje...
Redeye comments on G5’s Q1-results which saw a weaker topline than expected and while reported EBIT ...
Redeye updates its estimates following Freemelt’s Q1 report, which came in lower than expected in te...
We downgrade our 2025-27 sales estimates by ~8%, owing to FX, while we downgrade 2025E-27E adjusted ...
Redeye updates its estimates and fair value range following CTEK’s Q1 results, which exceeded our ex...
Acconeer's first quarter 2025 net sales growth of 20% y/y (or -12% adjusted for the postponed order)...
Redeye comments on the outcome of AcouSort’s rights issue.
Redeye remains positive to Bredband2 despite its soft Q1 margins driven by growth efforts.
Redeye retains its view of Hanza following a Q1 report showing a relatively solid performance in a s...
Redeye retains its positive view of Teneo AI despite a Q1 report on the soft side.
Soft Q1 sales of SEK 2.9m on no machine deliveries, but 6 orders Share issue readies balance sheet f...
Sales down 7% y-o-y, headwinds from weak end-markets persist Cut '25e-'27e sales by 4-2%, EBIT by SE...
Redeye provides its comment on Mendus’ Q1 2025 report.
Sales -13% vs cons, EBIT -60%, post a strong Q4 and tough comps Guides for higher military budgets p...
EBITA SEK 271m (+3% vs. ABG, +6% vs. IR cons) We expect cons EBITA upgrades of 3-4% for '25e 15-13x ...
Redeye interviewed Freemelt’s CEO, Daniel Gidlund, about the Q1 report and recently announced orders...
Embracer becomes a shareholder in Starbreeze through a directed new share issue of 9% of the total n...
Embracer blir delägare i Starbreeze genom en riktad nyemission på 9% av de totala antalet aktier i b...
